GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Qilu’s first Avastin biosimilar Ankada needs strong commercialization strategy in China, says GlobalData

China-based Qilu Pharmaceutical received approval in December 2019 for QL-1101 under the trade name Ankada, a biosimilar to Avastin (bevacizumab), to treat advanced, metastatic or recurrent non-small-cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Being the first approved Avastin biosimilar in China, Ankada will have the first-mover advantage, however its success will depend on a strong […]
Read more

GlobalData reveals top 10 HealthTech influencers in Q4 2019

The GlobalData’s HealthTech Influencer Platform, which tracks more than 225 leading global HealthTech experts across the globe and their discussions pertaining to the emerging trends, pain areas, new fields of innovation and other popular areas on Twitter, revealed technology expert and B2B thought leader Evan Kirstel as the top influencer in the fourth quarter (Q4) […]
Read more

India’s Union Budget 2020 provides strong initiatives for technology sector to remain on track for US$5 trillion economy by 2025, says GlobalData

The Indian Union Budget 2020 presented by the country’s Finance Minister Nirmala Sitharaman delivers a host of initiatives to boost the growth of the technology sector, which is a key component of the Narendra Modi government’s target of turning India into a US$5 trillion economy by 2025, says GlobalData, a leading data and analytics company. […]
Read more

GlobalData reveals top 10 cybersecurity influencers in Q4 2019

An analysis of GlobalData’s Cybersecurity Influencer Platform, which tracks more than 300 leading global cybersecurity experts and their discussions pertaining to the emerging trends, pain areas, new fields of innovation and other popular areas on Twitter, revealed cybersecurity expert Sean Harris as the top influencer during the fourth quarter (Q4) of 2019. SwiftOnSecurity, information security […]
Read more

Uncertain regulatory environment affecting growth and investments in India’s e-pharmacy sector, says GlobalData

Lack of progressive and proactive e-pharmacy regulatory framework is impacting the overall growth potential and future investments in the Indian e-pharmacy sector, says GlobalData, a leading data and analytics company.  In a bid to prohibit the unauthorized sale of medicines by certain e-pharmacies, the Drug Controller General of India (DCGI) ordered all states and union […]
Read more

Roche’s Accu-Chek SugarView app may disrupt India’s blood glucose monitoring market, says GlobalData

Roche has recently received CE approval for its Accu-Chek SugarView blood glucose monitoring app. The approval will allow Roche to market glucose monitoring products aggressively and will further strengthen its leadership position in India’s glucose monitoring market, says GlobalData, a leading data and analytics company. The company’s report, ‘Diabetes Care Devices – Insulin Pens – […]
Read more

Card payment value in Indonesia set to cross US$57bn in 2023, says GlobalData

The Indonesian market remains heavily cash-reliant with limited awareness of electronic payments and inadequate payment infrastructure. However, the country is making gradual progress to reduce cash dependence, with card payments value set to increase from IDR639.9 trillion (US$44.5bn) in 2019 to IDR821.2 trillion (US$57.1bn) in 2023, according to GlobalData, a leading data and analytics company. […]
Read more

Hybrid cloud services to drive APAC enterprise cloud services revenue to US$256bn by 2023, says GlobalData

The marketplace for enterprise cloud computing related services in Asia-Pacific (APAC) is forecast to grow at a compound annual growth rate (CAGR) of 19% from US$107.6bn in 2018 to US$256.4bn in 2023, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Cloud Computing in Asia Pacific: Telco Cloud Offers, Best Practices […]
Read more

Chinese health insurance business set to exceed US$136bn in 2022, says GlobalData

The health insurance business in China is projected to grow from CNY437.4bn (US$64.7bn) in 2017 to CNY921.1bn (US$136.6bn) in 2022, according to GlobalData, a leading data and analytics company. GlobalData’s report, ‘China General Insurance: Key trends and Opportunities to 2022’, reveals that health insurance, which contributes about 30% of the total Chinese general insurance business, […]
Read more
1 192 193 194 195 196 206